Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study
Technology in Cancer Research & Treatment · 2024
DOI: 10.1177/15330338231214236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Rongqiu Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Excellence in Systems Biomedicine of Pediatric Oncology, Department of Pediatric Hematology and Oncology, Chongqing Key Laboratory of …. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Acquired Immunodeficiency Syndrome, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Key Discipline Program of Guangzhou‐Viral Infectious Diseases, National Natural Science Foundation of China, Talent Program of Chongqing Health Commission, and Chongqing Science and Technology Bureau.
Abstract (Originalsprache)
Objectives
Studies on the prognosis and risk stratification of patients with acquired immune deficiency syndrome (AIDS) – related Burkitt lymphoma (AR-BL) are rare. We aim to construct a novel model to improve the risk assessment of these patients.
Methods
We retrospectively analyzed the clinical data of 34 patients over the past 10 years and the factors associated with progression-free survival (PFS) and overall survival (OS) were evaluated in univariate and multivariate Cox models. Then, the novel model consisting of screened factors was compared with the existing models.
Results
With a 37-month median follow-up, the overall 2-year PFS and OS rates were 40.50% and 36.18%, respectively. The OS of patients who received chemotherapy was better compared with those without chemotherapy ( P = .0012). Treatment with an etoposide, prednisone, oncovin, cyclophosphamide, and hydroxydaunorubicin-based regimen was associated with longer OS and PFS compared with a cyclophosphamide, doxorubicin, vincristine, and prednisone-based regimen (OS, P = .0002; PFS, P = .0158). Chemotherapy (hazard ratio [ HR] = 0.075; 95% confidence interval [CI], 0.009-0.614) and Eastern Cooperative Oncology Group Performance Status (ECOG PS) 2 to 4 ( HR = 4.738; 95% CI, 1.178-19.061) were independent prognostic factors of OS in multivariate analysis and we established a novel prognostic risk stratification model named GZ8H model with chemotherapy and ECOG PS.
Conclusion
GZ8H showed better stratification ability than the international prognostic index (IPI) or Burkitt lymphoma IPI (BL-IPI). Furthermore, the C-index of the nomogram used to predict OS was 0.884 in the entire cohort and the calibration curve showed excellent agreement between the predicted and actual results of OS. No human immunodeficiency virus-related factors were found to be associated with OS and PFS of AR-BL patients in our study. Overall, the clinical characteristics and outcomes in AR-BL were shown and prognostic factors for OS and PFS were identified in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Excellence in Systems Biomedicine of Pediatric Oncology, Department of Pediatric Hematology and Oncology, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development…
- Infectious Diseases Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Children's Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Rongqiu Liu
Förderung
- Medical Key Discipline Program of Guangzhou‐Viral Infectious Diseases
- National Natural Science Foundation of China
- Talent Program of Chongqing Health Commission, and Chongqing Science and Technology Bureau
- Municipal and University (Hospital) joint funding project of Guangzhou Municipal Science and Technology Bureau
- CQMU Program for Youth Innovation in Future Medicine
Zitieren
APA
Liu, R., Zhao, H., Xiao, G., Tao, Y., Tang, X., Feng, L., Liao, B., Liu, B., Guan, J., Li, L., Chen, Z., He, H., & You, H. (2024). Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231214236
Vancouver
Liu R, Zhao H, Xiao G, Tao Y, Tang X, Feng L, et al. Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338231214236
BibTeX
@article{Liu2024,
author = {Liu, Rongqiu and Zhao, Han and Xiao, Guanying and Tao, Yu and Tang, Xiaoping and Feng, Lizhi and Liao, Baolin and Liu, Bo and Guan, Jialong and Li, Linghua and Chen, Zhimin and He, Haolan and You, Hua},
title = {Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
doi = {10.1177/15330338231214236}
}
EUVIMED